Your browser doesn't support javascript.
loading
Safety and feasibility of ultrasound-triggered targeted drug delivery of doxorubicin from thermosensitive liposomes in liver tumours (TARDOX): a single-centre, open-label, phase 1 trial.
Lyon, Paul C; Gray, Michael D; Mannaris, Christophoros; Folkes, Lisa K; Stratford, Michael; Campo, Leticia; Chung, Daniel Y F; Scott, Shaun; Anderson, Mark; Goldin, Robert; Carlisle, Robert; Wu, Feng; Middleton, Mark R; Gleeson, Fergus V; Coussios, Constantin C.
Afiliación
  • Lyon PC; Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Department of Radiology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Institute of Biomedical Engineering, University of Oxford, Oxfor
  • Gray MD; Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
  • Mannaris C; Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
  • Folkes LK; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.
  • Stratford M; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.
  • Campo L; CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Oxford, UK.
  • Chung DYF; Department of Radiology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Scott S; Nuffield Department of Anaesthetics, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Anderson M; Department of Radiology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Goldin R; Centre for Pathology, Faculty of Medicine, Imperial College London, London, UK.
  • Carlisle R; Institute of Biomedical Engineering, University of Oxford, Oxford, UK.
  • Wu F; Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Middleton MR; Department of Oncology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Gleeson FV; Department of Radiology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
  • Coussios CC; Institute of Biomedical Engineering, University of Oxford, Oxford, UK. Electronic address: constantin.coussios@eng.ox.ac.uk.
Lancet Oncol ; 19(8): 1027-1039, 2018 08.
Article en En | MEDLINE | ID: mdl-30001990
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Doxorrubicina / Ultrasonografía / Hipertermia Inducida / Neoplasias Hepáticas / Antibióticos Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Lancet Oncol Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Doxorrubicina / Ultrasonografía / Hipertermia Inducida / Neoplasias Hepáticas / Antibióticos Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Lancet Oncol Año: 2018 Tipo del documento: Article